NEA Management Company as of Dec. 31, 2015
Portfolio Holdings for NEA Management Company
NEA Management Company holds 34 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Tesaro | 29.5 | $463M | 8.9M | 52.32 | |
Ardelyx (ARDX) | 11.9 | $187M | 10M | 18.12 | |
Groupon | 8.6 | $136M | 44M | 3.07 | |
Dermira | 7.7 | $121M | 3.5M | 34.61 | |
Opower | 6.0 | $95M | 9.0M | 10.56 | |
Epizyme | 5.2 | $83M | 5.1M | 16.02 | |
Nevro (NVRO) | 4.3 | $67M | 993k | 67.51 | |
Loxo Oncology | 3.2 | $51M | 1.8M | 28.45 | |
Glycomimetics (GLYC) | 3.1 | $49M | 8.6M | 5.72 | |
Trevena | 2.5 | $40M | 3.8M | 10.50 | |
Clovis Oncology | 2.5 | $40M | 1.1M | 35.00 | |
Lexicon Pharmaceuticals (LXRX) | 2.0 | $32M | 2.4M | 13.31 | |
Trivascular Technologies | 1.7 | $26M | 3.9M | 6.65 | |
Aerohive Networks | 1.5 | $24M | 4.7M | 5.11 | |
Care | 1.5 | $23M | 3.3M | 7.16 | |
Mirna Therapeutics | 1.2 | $19M | 3.0M | 6.25 | |
Tracon Pharmaceuticals | 1.1 | $18M | 1.9M | 9.24 | |
Strongbridge Bioph shs usd | 1.0 | $16M | 2.1M | 7.60 | |
Exelixis (EXEL) | 0.8 | $12M | 2.2M | 5.64 | |
Rigel Pharmaceuticals | 0.6 | $9.8M | 3.2M | 3.03 | |
Sunesis Pharmaceuticals | 0.5 | $7.0M | 7.8M | 0.90 | |
Arca Biopharma | 0.4 | $6.8M | 1.5M | 4.65 | |
Orexigen Therapeutics | 0.4 | $6.4M | 3.7M | 1.72 | |
Aurinia Pharmaceuticals (AUPH) | 0.4 | $6.3M | 2.5M | 2.47 | |
Champions Oncology (CSBR) | 0.4 | $5.6M | 1.6M | 3.57 | |
ArQule | 0.3 | $5.5M | 2.5M | 2.17 | |
Zosano Pharma | 0.3 | $4.9M | 2.2M | 2.28 | |
Zhone Technologies | 0.3 | $4.8M | 4.8M | 1.00 | |
Roka Bioscience | 0.2 | $4.0M | 3.2M | 1.23 | |
Paratek Pharmaceuticals | 0.1 | $2.4M | 125k | 18.97 | |
Catalyst Biosciences | 0.1 | $2.0M | 652k | 3.13 | |
Akari Therapeutics | 0.1 | $1.8M | 122k | 14.50 | |
Agile Therapeutics | 0.1 | $1.3M | 134k | 9.76 | |
Cerecor | 0.1 | $1.2M | 595k | 2.01 |